IGF1 Human Des1-3

Insulin-Like Growth Factor 1 Des (1-3) Human Recombinant
Cat. No.
BT17632
Source
Escherichia Coli.
Synonyms
Somatomedin C, IGF-I, IGFI, IGF1, IGF-IA, Mechano growth factor, MGF, Des(1-3), Des1-3, Des 1-3, Des (1-3), IGF-1 (4-70).
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 97.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

IGF-I Des(1-3) Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 67 amino acids (aa 4-70) and having a molecular mass of 7368.5 Dalton.
IGF-1 Des1-3 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
The insulin-like growth factors (IGFs), also known as somatomedins, are a family of peptides that play crucial roles in mammalian growth and development. IGF1 is a key mediator of growth hormone's (GH; MIM 139250) growth-promoting effects. Early research revealed that growth hormone did not directly stimulate sulfate incorporation into cartilage; instead, it acted through a serum component known as 'sulfation factor,' which was later renamed 'somatomedin' (Daughaday et al., 1972). Somatomedin C (IGF1), somatomedin A (IGF2; MIM 147470), and somatomedin B (MIM 193190) are the three main somatomedins that have been identified (Rotwein, 1986; Rosenfeld, 2003).
Description
IGF-I Des(1-3) Human Recombinant, produced in E. Coli, is a single, non-glycosylated polypeptide chain consisting of 67 amino acids (aa 4-70) with a molecular mass of 7368.5 Daltons. The purification of IGF-1 Des1-3 is achieved using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
The protein was lyophilized from a 0.2µm filtered solution at a concentration of 1mg/ml in 20mM PBS, pH 7.0.
Solubility
To reconstitute the lyophilized IGF-I des(1-3), it is recommended to dissolve it in sterile 18M-cm H₂O at a concentration of at least 100µg/ml. This solution can be further diluted into other aqueous solutions as needed.
Stability
Lyophilized IGF-I des(1-3) remains stable at room temperature for up to 3 weeks; however, it is recommended to store it desiccated at a temperature below -18°C. Once reconstituted, IGF1 des-1-3 should be stored at 4°C for 2-7 days. For long-term storage, it is advisable to store it below -18°C. To enhance stability during long-term storage, adding a carrier protein (0.1% HSA or BSA) is recommended. It is important to avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 97.0% using the following methods: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.
Biological Activity
The ED₅₀, determined by a cell proliferation assay using FDC-P1 cells, is less than 2.0 ng/ml. This corresponds to a specific activity of greater than 5 x 10⁵ units/mg.
Synonyms
Somatomedin C, IGF-I, IGFI, IGF1, IGF-IA, Mechano growth factor, MGF, Des(1-3), Des1-3, Des 1-3, Des (1-3), IGF-1 (4-70).
Source
Escherichia Coli.
Amino Acid Sequence
TLCGAELVDA LQFVCGDRGF YFNKPTGYGS SSRRAPQTGI VDECCFRSCD LRRLEMYCAP LKPAKSA.

Product Science Overview

Introduction

Insulin-Like Growth Factor 1 Des (1-3) (Human Recombinant), often abbreviated as IGF-1 Des (1-3), is a truncated form of the naturally occurring Insulin-Like Growth Factor 1 (IGF-1). This variant lacks the first three amino acids at the N-terminus, which significantly enhances its biological activity compared to the full-length IGF-1. IGF-1 Des (1-3) is primarily used in research and therapeutic applications due to its potent anabolic effects, promoting cell growth and development.

Biological Significance

IGF-1 is a hormone similar in molecular structure to insulin and plays a crucial role in childhood growth and continues to have anabolic effects in adults. IGF-1 Des (1-3) binds to the IGF-1 receptor with higher affinity than the full-length IGF-1, leading to more pronounced effects on cell proliferation and differentiation. This makes it a valuable tool in both clinical and laboratory settings.

Preparation Methods

The recombinant form of IGF-1 Des (1-3) is typically produced using Escherichia coli (E. coli) as the host organism. The gene encoding IGF-1 Des (1-3) is inserted into a plasmid vector, which is then introduced into E. coli cells. These cells are cultured under specific conditions to express the protein. The expressed protein is harvested from the cells, purified through a series of chromatography steps, and then refolded to achieve its active conformation.

Chemical Reactions and Analysis

IGF-1 Des (1-3) undergoes various chemical reactions during its synthesis and purification. The initial step involves the expression of the protein in inclusion bodies within the E. coli cells. These inclusion bodies are then solubilized using denaturing agents, and the protein is purified using techniques such as ion-exchange chromatography and size-exclusion chromatography. The final product is analyzed using methods like mass spectrometry and high-performance liquid chromatography (HPLC) to ensure its purity and correct folding.

Applications

IGF-1 Des (1-3) has a wide range of applications in both research and medicine. In research, it is used to study cell growth, differentiation, and apoptosis. In medicine, it has potential therapeutic applications in conditions such as growth hormone insensitivity, muscle wasting diseases, and certain types of cancer. Its ability to promote muscle growth and repair also makes it of interest in sports medicine and anti-aging research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.